about
Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphomaHigh-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphomaPositron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patientsComparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphomaHigh-dose chemotherapy followed by autologous stem cell transplantation for refractory/relapsed Hodgkin lymphoma patientsChemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphomaComparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphomaChemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin LymphomaEffects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished dataCombined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review.Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.Application of MALDI imaging for the diagnosis of classical Hodgkin lymphoma.Vitamin D and non-Hodgkin lymphoma risk in adults: a reviewPediatric lymphomas in Brazil.Hodgkin lymphoma in childhood: clinicopathological features and therapy outcome at 2 centers from a developing country.Hodgkin's disease of the oesophagus: a literature review.Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy.Rare Clinical Sign of Hodgkin's Lymphoma: Ocular Involvement.Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.Nonrandom occurrence of lymphoid cancer types in 140 families.No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study.Incidence and outcomes of women with Hodgkin's lymphoma in pregnancy: a population-based study on 7.9 million births.High frequency of primary refractory disease and low progression-free survival rate of Hodgkin's lymphoma: a decade of experience in a Latin American center.Risk of second cancer after lymphohematopoietic neoplasm.EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph).Overview and outcome of Hodgkin's Lymphoma: Experience of a single developing country's oncology centre.The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma.
P2860
Q24186668-84362B30-B566-4D38-9BFE-B661260F49E5Q24201885-76FDFC7E-BD7E-4C33-8242-9CD1CCB0A500Q24202622-BCFC38B8-D025-4C28-A7CA-553CB109172BQ24234975-DAC1059C-E969-483A-B71D-821BF89BA47EQ24235563-4817CE6E-E0E5-4D4C-8851-D9E01ECD3A66Q24236589-729DBD4C-1C7C-40AB-A932-56B366761034Q24240697-98E05980-AD65-419B-85FF-5A8FC57B2F07Q24243379-BB6EABE6-7682-4D92-98A8-96B1561D7EAFQ30803363-03166536-1353-4D84-B914-B00AD68D3044Q30937299-D8B12B55-7FBA-471B-8A98-256D3574A8EEQ33372701-AFF1337F-0DF8-4DF4-A2F2-18D304198FA6Q33442092-EDCFFAA0-FB69-41DD-85DA-F884BF0BF8ABQ33701896-9ADCE0BD-3F36-4422-9AFC-18E8F9075A79Q33946304-08BE9920-7876-4E9A-A44A-CFCACC56016EQ34486959-E4D4B5FA-E9D5-48CE-9EAD-234992074451Q36151188-C47F746A-EF37-4EAF-ABE0-A708D0BA6D57Q36931036-9CFBC1D5-8CDF-47BF-91C2-C7B1C6F898A3Q37416478-146A4746-604D-473D-9492-7F9C0BF26B95Q37741123-8F1AEDC7-649B-4635-A897-6E39155D7E29Q38817696-BFA464CD-EF46-4ED1-A82F-684539C07234Q38917144-AE4D7F1D-1E00-46F7-9675-E81FA2290D2AQ40929122-F4856C98-FBC2-4F0D-813E-12F83520D6CCQ46315398-36F0A63A-296F-4CC2-9681-5B4656479F87Q46879226-8CA308D4-ECDE-4EBE-8A90-C9C34C609935Q51539401-027A1895-A570-41D3-9AE1-16F011AC0684Q51735191-7C708BA4-400A-488E-AF11-04C4331A7A40Q53260519-E3EFA71C-8DB8-4B30-86EB-B13F9A6D3BAEQ55153751-78CFE24C-4DF7-4E3C-973E-D1C848436EBAQ55495617-43B79F1B-8733-403E-ACFB-E8613DE19FF5
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Epidemiology and etiology of Hodgkin's lymphoma.
@ast
Epidemiology and etiology of Hodgkin's lymphoma.
@en
Epidemiology and etiology of Hodgkin's lymphoma.
@nl
type
label
Epidemiology and etiology of Hodgkin's lymphoma.
@ast
Epidemiology and etiology of Hodgkin's lymphoma.
@en
Epidemiology and etiology of Hodgkin's lymphoma.
@nl
prefLabel
Epidemiology and etiology of Hodgkin's lymphoma.
@ast
Epidemiology and etiology of Hodgkin's lymphoma.
@en
Epidemiology and etiology of Hodgkin's lymphoma.
@nl
P2093
P356
P1433
P1476
Epidemiology and etiology of Hodgkin's lymphoma.
@en
P2093
P304
P356
10.1093/ANNONC/MDF652
P478
13 Suppl 4
P577
2002-01-01T00:00:00Z